<SEC-DOCUMENT>0001564590-20-018057-index.html : 20200423
<SEC-HEADER>0001564590-20-018057.hdr.sgml : 20200423
<ACCEPTANCE-DATETIME>20200423083033
ACCESSION NUMBER:		0001564590-20-018057
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200608
FILED AS OF DATE:		20200423
DATE AS OF CHANGE:		20200423
EFFECTIVENESS DATE:		20200423

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aeglea BioTherapeutics, Inc.
		CENTRAL INDEX KEY:			0001636282
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				464312787
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37722
		FILM NUMBER:		20809242

	BUSINESS ADDRESS:	
		STREET 1:		805 LAS CIMAS PARKWAY
		STREET 2:		SUITE 100
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746
		BUSINESS PHONE:		(512) 942-2935

	MAIL ADDRESS:	
		STREET 1:		805 LAS CIMAS PARKWAY
		STREET 2:		SUITE 100
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>agle-def14a_20200608.htm
<DESCRIPTION>DEF 14A
<TEXT>
Document 1 - file: agle-def14a_20200608.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>ggmfp314tr5p000003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: ggmfp314tr5p000003.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ggmfp314tr5p000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: ggmfp314tr5p000001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ggmfp314tr5p000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: ggmfp314tr5p000002.jpg

</DOCUMENT>
</SEC-DOCUMENT>